{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T01:47:30Z","timestamp":1783648050129,"version":"3.55.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvir.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular and Interventional Radiology"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.jvir.2020.05.019","type":"journal-article","created":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T00:05:49Z","timestamp":1601251549000},"page":"1627-1635","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Chronic Hepatotoxicity in Patients with Metastatic Neuroendocrine Tumor: Transarterial Chemoembolization versus Transarterial Radioembolization"],"prefix":"10.1016","volume":"31","author":[{"given":"Brian M.","family":"Currie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Nadolski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Mondschein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandeep","family":"Dagli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Sudheendra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. William","family":"Stavropoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Soulen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvir.2020.05.019_bib1","doi-asserted-by":"crossref","DOI":"10.6004\/jnccn.2018.0056","article-title":"NCCN guidelines insights: neuroendocrine and adrenal tumors, version 2.2018","author":"Shah","year":"2018","journal-title":"J\u00a0Natl Compr Cancer Netw"},{"key":"10.1016\/j.jvir.2020.05.019_bib2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000335597","article-title":"ENETS consensus guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary","volume":"95","author":"Pavel","year":"2012","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.jvir.2020.05.019_bib3","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/MPA.0000000000000850","article-title":"The North American Neuroendocrine Tumor Society consensus guidelines for surveillance and medical management of midgut neuroendocrine tumors","volume":"46","author":"Strosberg","year":"2017","journal-title":"Pancreas"},{"key":"10.1016\/j.jvir.2020.05.019_bib4","doi-asserted-by":"crossref","first-page":"692","DOI":"10.2214\/AJR.11.7066","article-title":"Chemoembolization practice patterns and technical methods among interventional radiologists: results of an online survey","volume":"198","author":"Gaba","year":"2012","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jvir.2020.05.019_bib5","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/cncr.23339","article-title":"Liver disease induced by radioembolization of liver tumors: description and possible risk factors","volume":"112","author":"Sangro","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.jvir.2020.05.019_bib6","doi-asserted-by":"crossref","unstructured":"Braat MNGJA, Erpecum KJ Van, Zonnenberg BA, Bosch MAJ Van Den. Radioembolization-induced liver disease : a systematic review. 2017;45:144\u2013152.","DOI":"10.1097\/MEG.0000000000000772"},{"key":"10.1016\/j.jvir.2020.05.019_bib7","doi-asserted-by":"crossref","unstructured":"Gil-alzugaray B, Chopitea A, Mercedes I, et\u00a0al. Prognostic factors and prevention of radioembolization-induced liver disease. 2012:1078\u20131087.","DOI":"10.1002\/hep.26191"},{"key":"10.1016\/j.jvir.2020.05.019_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.humpath.2008.06.024","article-title":"Hepatobiliary effects of 90yttrium microsphere therapy for unresectable hepatocellular carcinoma","author":"Nalesnik","year":"2009","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jvir.2020.05.019_bib9","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/COC.0b013e31827deea1","article-title":"Impact of prior hepatectomy on the safety and efficacy of radioembolization with yttrium-90 microspheres for patients with unresectable liver tumors","volume":"37","author":"Bester","year":"2014","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.jvir.2020.05.019_bib10","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1055\/s-2006-941442","article-title":"Complications of hepatic chemoembolization","volume":"23","author":"Clark","year":"2006","journal-title":"Semin Intervent Radiol"},{"key":"10.1016\/j.jvir.2020.05.019_bib11","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000367739","article-title":"Surgical and locoregional therapy of HCC: TACE","volume":"4","author":"Tsurusaki","year":"2015","journal-title":"Liver Cancer"},{"key":"10.1016\/j.jvir.2020.05.019_bib12","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.ciresp.2018.06.004","article-title":"Complications of transarterial chemoembolization (TACE) in the treatment of liver tumors","volume":"96","author":"Marcacuzco Quinto","year":"2018","journal-title":"Cir ESP"},{"key":"10.1016\/j.jvir.2020.05.019_bib13","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1051-0443(07)61911-3","article-title":"Determinants of postembolization syndrome after hepatic chemoembolization","volume":"12","author":"Leung","year":"2001","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2020.05.019_bib14","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1007\/s10620-007-0148-z","article-title":"Fibrosis, portal hypertension, and hepatic volume changes induced by intra-arterial radiotherapy with 90Yttrium microspheres","volume":"53","author":"Jakobs","year":"2008","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jvir.2020.05.019_bib15","doi-asserted-by":"crossref","unstructured":"Kuo JC, Tazbirkova A, Allen R, Kosmider S, Gibbs P, Yip D. Serious hepatic complications of selective internal radiation therapy with yttrium-90 microsphere radioembolization for unresectable liver tumors. 2014:266\u2013272.","DOI":"10.1111\/ajco.12229"},{"key":"10.1016\/j.jvir.2020.05.019_bib16","doi-asserted-by":"crossref","unstructured":"Maleux G, Deroose C, Laenen A, et\u00a0al. Yttrium-90 radioembolization for the treatment of chemorefractory colorectal liver metastases : technical results, clinical outcome and factors potentially influencing survival.\u00a02016; 55:486\u2013495.","DOI":"10.3109\/0284186X.2015.1101151"},{"key":"10.1016\/j.jvir.2020.05.019_bib17","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.2214\/AJR.06.0933","article-title":"Long-term outcome after chemoembolization and embolization of hepatic metastatic lesions from neuroendocrine tumors","volume":"188","author":"Ho","year":"2007","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jvir.2020.05.019_bib18","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1148\/radiology.215.1.r00ap21123","article-title":"Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with cirrhosis: evaluation of damage to nontumorous liver tissue-long-term prospective study","volume":"215","author":"Caturelli","year":"2000","journal-title":"Radiology"},{"key":"10.1016\/j.jvir.2020.05.019_bib19","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.jvir.2018.02.002","article-title":"Long-Term Toxicity after Transarterial Radioembolization with Yttrium-90 Using Resin Microspheres for Neuroendocrine Tumor Liver Metastases","volume":"29","author":"Tomozawa","year":"2018","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2020.05.019_bib20","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1016\/j.jvir.2017.05.011","article-title":"Long-term hepatotoxicity of yttrium-90 radioembolization as treatment of metastatic neuroendocrine tumor to the liver","volume":"28","author":"Su","year":"2017","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2020.05.019_bib21","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/j.jvir.2019.06.003","article-title":"Radioembolization-induced chronic hepatotoxicity: a single-center cohort analysis","volume":"30","author":"Currie","year":"2019","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2020.05.019_bib22","series-title":"SIR-Spheres [package insert]","year":"2016"},{"key":"10.1016\/j.jvir.2020.05.019_bib23","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1053\/tvir.2002.36422","article-title":"Chemoembolization for hepatic metastases","volume":"5","author":"Gee","year":"2002","journal-title":"Tech Vasc Interv Radiol"}],"container-title":["Journal of Vascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051044320305030?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051044320305030?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T06:04:47Z","timestamp":1760940287000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1051044320305030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":23,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S1051044320305030"],"URL":"https:\/\/doi.org\/10.1016\/j.jvir.2020.05.019","relation":{},"ISSN":["1051-0443"],"issn-type":[{"value":"1051-0443","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic Hepatotoxicity in Patients with Metastatic Neuroendocrine Tumor: Transarterial Chemoembolization versus Transarterial Radioembolization","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular and Interventional Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvir.2020.05.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 SIR, 2020","name":"copyright","label":"Copyright"}]}}